Literature DB >> 12123836

Cytoskeleton-related trafficking of the EAAC1 glutamate transporter after activation of the G(q/11)-coupled neurotensin receptor NTS1.

Mustapha Najimi1, Jean Marie Maloteaux, Emmanuel Hermans.   

Abstract

The possible modulation of the glutamate transporter EAAC1 by a class A G protein-coupled receptor was studied in transfected C6 glioma cells stably expressing the high-affinity neurotensin receptor NTS1. Brief exposure (5 min) to neurotensin increased Na(+)-dependent D-[(3)H]aspartate uptake by about 70%. The effect of neurotensin was found to result from an increase in cell surface expression of EAAC1 and accordingly, cytochalasin D and colchicine were shown to block the effect of neurotensin on aspartate uptake, suggesting that the cytoskeleton participates in this regulation. Neither protein kinase C nor phosphatidylinositol 3-kinase activities, two intracellular signaling pathways known to modulate EAAC1, was required for EAAC1-mediated aspartate transport regulation by neurotensin. Together, these results provide evidence for an acute regulation of EAAC1 trafficking after activation of a G protein-coupled receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12123836     DOI: 10.1016/s0014-5793(02)02981-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter.

Authors:  Ana Marin D Carneiro; Randy D Blakely
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

Review 2.  The importance of the excitatory amino acid transporter 3 (EAAT3).

Authors:  Walden E Bjørn-Yoshimoto; Suzanne M Underhill
Journal:  Neurochem Int       Date:  2016-05-24       Impact factor: 3.921

3.  Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.

Authors:  Xianyong Gui; Shuhong Liu; Yuchu Yan; Zuhua Gao
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

4.  Suppression of neurotensin receptor type 1 expression and function by histone deacetylase inhibitors in human colorectal cancers.

Authors:  Xiaofu Wang; Lindsey N Jackson; Sara M Johnson; Qingding Wang; B Mark Evers
Journal:  Mol Cancer Ther       Date:  2010-07-27       Impact factor: 6.261

5.  Muscarinic receptor stimulation of D-aspartate uptake into human SH-SY5Y neuroblastoma cells is attenuated by hypoosmolarity.

Authors:  Daniel J Foster; Anne M Heacock; Stephen K Fisher
Journal:  J Pharmacol Exp Ther       Date:  2010-01-15       Impact factor: 4.030

Review 6.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

Review 7.  Rapid Regulation of Glutamate Transport: Where Do We Go from Here?

Authors:  Alain M Guillem; Elizabeth N Krizman; Michael B Robinson
Journal:  Neurochem Res       Date:  2021-04-24       Impact factor: 3.996

Review 8.  New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.

Authors:  Jan Korbecki; Izabela Gutowska; Ireneusz Kojder; Dariusz Jeżewski; Marta Goschorska; Agnieszka Łukomska; Anna Lubkowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Oncotarget       Date:  2018-01-09

9.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.

Authors:  Zherui Wu; Daniel Martinez-Fong; Jean Trédaniel; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-17       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.